Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Longitude Capital
Biotech
Past and present GSK execs take on new roles—Chutes & Ladders
GSK marketing exec takes C-suite role at biotech; Ex-GSK oncology leader takes Anagenex CSO role; Janssen vet heads to psychedelics-based Freedom.
Max Bayer
,
Gabrielle Masson
Nov 18, 2022 9:30am
Endeavor nabs $101M for IPF, cancer trials—and asset shopping
Feb 7, 2022 8:00am
Longitude Capital raises $585M in 4th-round fund
Sep 23, 2020 7:00am
Novo helps lead Checkmate's $85M raise for single asset
Jun 11, 2020 7:30am
Murj scoops $8.5M to enable boom in devices and data
May 9, 2018 9:30am
Rapid Micro bags $60M to grow microbial detection business
May 2, 2018 12:01am
